RhumbLine Advisers’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $257M | Sell |
|
|||||
|
2025
Q1 | $328M | Sell |
|
|||||
|
2024
Q4 | $346M | Sell |
|
|||||
|
2024
Q3 | $418M | Sell |
|
|||||
|
2024
Q2 | $385M | Sell |
|
|||||
|
2024
Q1 | $414M | Buy |
|
|||||
|
2023
Q4 | $378M | Sell |
|
|||||
|
2023
Q3 | $363M | Buy |
|
|||||
|
2023
Q2 | $372M | Buy |
|
|||||
|
2023
Q1 | $403M | Buy |
|
|||||
|
2022
Q4 | $380M | Buy |
|
|||||
|
2022
Q3 | $334M | Buy |
|
|||||
|
2022
Q2 | $350M | Buy |
|
|||||
|
2022
Q1 | $362M | Buy |
|
|||||
|
2021
Q4 | $401M | Buy |
|
|||||
|
2021
Q3 | $340M | Sell |
|
|||||
|
2021
Q2 | $307M | Sell |
|
|||||
|
2021
Q1 | $292M | Sell |
|
|||||
|
2020
Q4 | $319M | Sell |
|
|||||
|
2020
Q3 | $305M | Buy |
|
|||||
|
2020
Q2 | $240M | Buy |
|
|||||
|
2020
Q1 | $179M | Buy |
|
|||||
|
2019
Q4 | $205M | Sell |
|
|||||
|
2019
Q3 | $184M | Buy |
|
|||||
|
2019
Q2 | $183M | Sell |
|
|||||
|
2019
Q1 | $174M | Sell |
|
|||||
|
2018
Q4 | $146M | Buy |
|
|||||
|
2018
Q3 | $157M | Sell |
|
|||||
|
2018
Q2 | $135M | Buy |
|
|||||
|
2018
Q1 | $131M | Sell |
|
|||||
|
2017
Q4 | $122M | Buy |
|
|||||
|
2017
Q3 | $117M | Buy |
|
|||||
|
2017
Q2 | $104M | Sell |
|
|||||
|
2017
Q1 | $92.7M | Sell |
|
|||||
|
2016
Q4 | $87M | Buy |
|
|||||
|
2016
Q3 | $94.3M | Buy |
|
|||||
|
2016
Q2 | $78.6M | Buy |
|
|||||
|
2016
Q1 | $72.5M | Buy |
|
|||||
|
2015
Q4 | $69.9M | Sell |
|
|||||
|
2015
Q3 | $60.5M | Sell |
|
|||||
|
2015
Q2 | $64.6M | Sell |
|
|||||
|
2015
Q1 | $78.6M | Sell |
|
|||||
|
2014
Q4 | $73.4M | Sell |
|
|||||
|
2014
Q3 | $72.6M | Sell |
|
|||||
|
2014
Q2 | $70.8M | Buy |
|
|||||
|
2014
Q1 | $69.2M | Buy |
|
|||||
|
2013
Q4 | $62.1M | Sell |
|
|||||
|
2013
Q3 | $53.6M | Sell |
|
|||||
|
2013
Q2 | $49.9M | Buy |
|